Skip to main content

UBS Group AG

Position in IMUX — Immunic, Inc.

CIK 1610520 ZURICH, V8

Position in IMUX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$580,303
+$293,484 QoQ
Shares Held
522,797
-2.7% QoQ
Ownership
3.84%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. IMUX ranks #278 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMUX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $580,303 522,797
2025-12-31 $286,819 537,118
2025-09-30 $34,121 38,687
2025-06-30 $262,519 376,104
2025-03-31 $162,463 149,050
2024-12-31 $27,197 27,197
2024-09-30 $4,024 2,439
2024-06-30 $1,502 1,354
2024-03-31 $12,099 9,167
2023-12-31 $15,571 10,381
2023-09-30 $4,533 3,084
2023-06-30 $62 25
2023-03-31 $14,932 10,022
2022-12-31 $35 25
2022-09-30 $11,919 3,772
2022-06-30 $255,269 73,565
2022-03-31 $8,282 733
2021-12-31 $48,969 5,117
2021-09-30 $19,452 2,198
2021-06-30 $44,393 3,621
2020-09-30 $36,267 1,953
2020-06-30 $12,859 1,061
2020-03-31 $19,372 3,202